Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation

Nature Communications

Volumn 4, Issue , 2013, Pages

  Kabata, Hiroki ^a,b   Moro, Kazuyo ^b,c,d   Fukunaga, Koichi ^a   Suzuki, Yusuke ^a   Miyata, Jun ^a   Masaki, Katsunori ^a   Betsuyaku, Tomoko ^a   Koyasu, Shigeo ^a,b   Asano, Koichiro ^a,e  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 25; INTERLEUKIN 27; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 9; NEUTRALIZING ANTIBODY; PIMOZIDE; PROTEIN BCL XL; STAT5 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; BCL2L1 PROTEIN, MOUSE; CORTICOSTEROID; CYTOKINE; DOPAMINE RECEPTOR BLOCKING AGENT; INTERLEUKIN 33, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, MOUSE; PROTEIN BCL X;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; EOSINOPHIL; HELPER CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; ANIMAL; ASTHMA; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG TOLERANCE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; LUNG; PATHOLOGY; PHOSPHORYLATION;

ADRENAL CORTEX HORMONES; ANIMALS; ANTIBODIES, NEUTRALIZING; ASTHMA; BCL-X PROTEIN; CYTOKINES; DOPAMINE ANTAGONISTS; DRUG TOLERANCE; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKINS; LUNG; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PIMOZIDE; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84896849811     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3675     Document Type: Article

References (42)

1. Rhen, T. & Cidlowski, J. A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N. Engl. J. Med. 353, 1711-1723 (2005).
2. van der Velden, V. H. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. Mediators Inflamm. 7, 229-237 (1998).
3. Wallen, N., Kita, H., Weiler, D. & Gleich, G. J. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J. Immunol. 147, 3490-3495 (1991).
4. Holgate, S. T. & Polosa, R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 368, 780-793 (2006).
5. Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490 (2005).
6. Wan, Y. I. et al. Genome-wide association study to identify genetic determinants of severe asthma. Thorax 67, 762-768 (2012).
7. Smith, D. E. IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin. Exp. Aller. 40, 200-208 (2010).
8. Prefontaine, D. et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183, 5094-5103 (2009).
9. Kondo, Y. et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 20, 791-800 (2008).
10. + lymphoid cells. Nature 463, 540-544 (2010).
11. Spits, H. et al. Innate lymphoid cells - a proposal for a uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013).
12. Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367-1370 (2010).
13. Price, A. E. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl Acad. Sci. USA 107, 11489-11494 (2010).
14. Mjösberg, J. M. et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12, 1055-1062 (2011).
15. Halim, T. Y., Krauss, R. H., Sun, A. C. & Takei, F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36, 451-463 (2012).
16. Wolterink, R. G. et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur. J. Immunol. 42, 1106-1116 (2012).
17. Kim, H. Y. et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J. Aller. Clin. Immunol. 129, 216-227e211-216-227e216 (2012).
18. Yasuda, K. et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc. Natl Acad. Sci. USA 109, 3451-3456 (2012).
19. Kouzaki, H., Iijima, K., Kobayashi, T., O'Grady, S. M. & Kita, H. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J. Immunol. 186, 4375-4387 (2011).
20. Monticelli, L. A. et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045-1054 (2011).
21. Chang, Y. J. et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12, 631-638 (2011).
22. Shikotra, A. et al. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J. Aller. Clin. Immunol. 129, 104-111e101-104-111e109 (2012).
23. + myeloid population that exaxerbates asthatic pathology. Nat. Med. 18, 751-757 (2012).
24. Trifilieff, A., El-Hashim, A. & Bertrand, C. Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L1120-L1128 (2000).
25. Blyth, D. I. et al. Induction, duration, and resolution of airway goblet cell hyperplasia in a murine model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone. Am. J. Respir. Cell. Mol. Biol. 19, 38-54 (1998).
26. Zhou, B. et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 6, 1047-1053 (2005).
27. Ferreira, D. S. et al. Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthma. Clin. Exp. Aller. 42, 1459-1471 (2012).
28. Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634-648 (2012).
29. + type 2 innate lymphoid cells. Proc. Natl Acad. Sci. USA 110, 10240-10245 (2013).
30. Furusawa, J.-I. et al. Critical role of p38 and GATA3 in natural helper cell function. J. Immunol. 191, 1818-1826 (2013).
31. Goleva, E., Kisich, K. O. & Leung, D. Y. A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. J. Immunol. 169, 5934-5940 (2002).
32. Nelson, E. A. et al. The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukaemia cells resistant to kinase inhibitors. Blood 117, 3421-3429 (2011).
33. hi lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 188, 1503-1513 (2012).
34. + T cells. J. Clin. Invest. 113, 619-627 (2004).
35. Irusen, E. et al. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J. Aller. Clin. Immunol. 109, 649-657 (2002).
36. Sade, H. & Sarin, A. IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells. Eur. J. Immunol. 33, 913-919 (2003).
37. Takai, T. TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol. Int. 61, 3-17 (2012).
38. c family cytokines. Nat. Rev. Immunol. 9, 480-490 (2009).
39. Pandey, A. et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat. Immunol. 1, 59-64 (2000).
40. + effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway. Immunology 130, 418-426 (2010).
41. Sirota, M. et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Trans Med. 3, 96ra77 (2011).
42. Nick, C. et al. Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development. Mol. Cell Biol. 24, 2584-2592 (2004).